DMD and Duchenne muscular dystrophy: Cell therapies for DMD aim to deliver dystrophin‐expressing cells, either donor‐derived or genetically corrected patient‐specific cells, capable of crossing vascular barriers, integrating into host myocardium and evading immune rejection.